Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT00379340
Registration number
NCT00379340
Ethics application status
Date submitted
19/09/2006
Date registered
21/09/2006
Date last updated
16/04/2024
Titles & IDs
Public title
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Query!
Scientific title
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Query!
Secondary ID [1]
0
0
NCI-2009-00419
Query!
Secondary ID [2]
0
0
AREN0533
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Stage III Kidney Wilms Tumor
0
0
Query!
Stage IV Kidney Wilms Tumor
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Children's - Other
Query!
Cancer
0
0
0
0
Query!
Kidney
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Other - 3-Dimensional Conformal Radiation Therapy
Treatment: Surgery - Conventional Surgery
Treatment: Drugs - Cyclophosphamide
Other interventions - Dactinomycin
Treatment: Drugs - Doxorubicin Hydrochloride
Treatment: Drugs - Etoposide
Treatment: Drugs - Vincristine Sulfate Liposome
Experimental: Treatment (chemotherapy, surgery, radiotherapy) - REGIMEN DD4A (weeks 1-6): Patients receive dactinomycin IV; vincristine IV; and doxorubicin hydrochloride IV. Patients with pulmonary and extra-pulmonary metastases at diagnosis undergo radiotherapy.
Patients with initially unresectable or incompletely resected tumors are reevaluated at week 6, and if resectable, undergo surgery and then proceed to either regimen DD4A or regimen M.
REGIMEN DD4A (weeks 7-25): Patients receive dactinomycin IV; vincristine IV; and doxorubicin hydrochloride IV.
REGIMEN M (weeks 7-31): Patients receive cyclophosphamide IV; vincristine IV; and dactinomycin IV and doxorubicin hydrochloride IV. Patients with pulmonary metastases only who are SIR also undergo whole lung radiotherapy.
Treatment: Other: 3-Dimensional Conformal Radiation Therapy
Treatment: Surgery: Conventional Surgery
Treatment: Drugs: Cyclophosphamide
Given IV
Other interventions: Dactinomycin
Given IV
Treatment: Drugs: Doxorubicin Hydrochloride
Given IV
Treatment: Drugs: Etoposide
Given IV
Treatment: Drugs: Vincristine Sulfate Liposome
Given IV
Query!
Intervention code [1]
0
0
Treatment: Other
Query!
Intervention code [2]
0
0
Treatment: Surgery
Query!
Intervention code [3]
0
0
Treatment: Drugs
Query!
Intervention code [4]
0
0
Other interventions
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Event Free Survival Probability
Query!
Assessment method [1]
0
0
Probability of no relapse, secondary malignancy, or death after 4 year in the study.
Query!
Timepoint [1]
0
0
4 years
Query!
Primary outcome [2]
0
0
Event Free Survival (EFS) Probability
Query!
Assessment method [2]
0
0
Probability of no relapse, secondary malignancy, or death after 4 year in the study.
Query!
Timepoint [2]
0
0
At 4 years
Query!
Primary outcome [3]
0
0
Event Free Survival Probability
Query!
Assessment method [3]
0
0
Probability of no relapse, secondary malignancy, or death after 4 year in the study
Query!
Timepoint [3]
0
0
At 4 years
Query!
Secondary outcome [1]
0
0
Event Free Survival Associated With the Burden of Pulmonary Metastatic Disease
Query!
Assessment method [1]
0
0
Probability of no relapse, secondary malignancy, or death after 4 year in the study.
Query!
Timepoint [1]
0
0
At 4 years
Query!
Eligibility
Key inclusion criteria
- Newly diagnosed Wilms' tumor meeting 1 of the following criteria:
- Stage IV disease with favorable histology with or without loss of heterozygosity
(LOH) for 1p and 16q
- Stage III disease with favorable histology with LOH for 1p and 16q transferring
from clinical trial COG-AREN0532
- Patients must begin therapy within 14 days after surgery or biopsy, unless medically
contraindicated
- No bilateral Wilms' tumors (stage IV)
- Patients should be referred to COG-AREN0534
- Previously enrolled in clinical trial COG-AREN03B2
- Karnofsky performance status (PS) 50-100% (for patients > 16 years of age) OR Lansky
PS 50-100% (for patients = 16 years of age)
- Bilirubin = 1.5 times upper limit of normal (ULN)
- AST or ALT < 2.5 times ULN
- Shortening fraction = 27% by echocardiogram OR ejection fraction = 50% by radionuclide
angiogram
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception
- No prior tumor-directed chemotherapy or radiotherapy unless transferring from clinical
trial COG-AREN0532 OR treatment for emergent issues, as medically indicated
- No concurrent aprepitant
Query!
Minimum age
No limit
Query!
Query!
Maximum age
29
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
N/A
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Active, not recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
26/02/2007
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
395
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC,WA
Query!
Recruitment hospital [1]
0
0
Sydney Children's Hospital - Randwick
Query!
Recruitment hospital [2]
0
0
The Children's Hospital at Westmead - Westmead
Query!
Recruitment hospital [3]
0
0
Royal Brisbane and Women's Hospital - Herston
Query!
Recruitment hospital [4]
0
0
Royal Children's Hospital-Brisbane - Herston
Query!
Recruitment hospital [5]
0
0
Queensland Children's Hospital - South Brisbane
Query!
Recruitment hospital [6]
0
0
Women's and Children's Hospital-Adelaide - North Adelaide
Query!
Recruitment hospital [7]
0
0
Royal Children's Hospital - Parkville
Query!
Recruitment hospital [8]
0
0
Princess Margaret Hospital for Children - Perth
Query!
Recruitment postcode(s) [1]
0
0
2031 - Randwick
Query!
Recruitment postcode(s) [2]
0
0
2145 - Westmead
Query!
Recruitment postcode(s) [3]
0
0
4029 - Herston
Query!
Recruitment postcode(s) [4]
0
0
4101 - South Brisbane
Query!
Recruitment postcode(s) [5]
0
0
5006 - North Adelaide
Query!
Recruitment postcode(s) [6]
0
0
3052 - Parkville
Query!
Recruitment postcode(s) [7]
0
0
6008 - Perth
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Alabama
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Arizona
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
Arkansas
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
California
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Colorado
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Connecticut
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Delaware
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
District of Columbia
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Florida
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Georgia
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Hawaii
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Idaho
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Illinois
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Indiana
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
Iowa
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
Kansas
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
Kentucky
Query!
Country [18]
0
0
United States of America
Query!
State/province [18]
0
0
Louisiana
Query!
Country [19]
0
0
United States of America
Query!
State/province [19]
0
0
Maine
Query!
Country [20]
0
0
United States of America
Query!
State/province [20]
0
0
Maryland
Query!
Country [21]
0
0
United States of America
Query!
State/province [21]
0
0
Massachusetts
Query!
Country [22]
0
0
United States of America
Query!
State/province [22]
0
0
Michigan
Query!
Country [23]
0
0
United States of America
Query!
State/province [23]
0
0
Minnesota
Query!
Country [24]
0
0
United States of America
Query!
State/province [24]
0
0
Mississippi
Query!
Country [25]
0
0
United States of America
Query!
State/province [25]
0
0
Missouri
Query!
Country [26]
0
0
United States of America
Query!
State/province [26]
0
0
Nebraska
Query!
Country [27]
0
0
United States of America
Query!
State/province [27]
0
0
Nevada
Query!
Country [28]
0
0
United States of America
Query!
State/province [28]
0
0
New Hampshire
Query!
Country [29]
0
0
United States of America
Query!
State/province [29]
0
0
New Jersey
Query!
Country [30]
0
0
United States of America
Query!
State/province [30]
0
0
New Mexico
Query!
Country [31]
0
0
United States of America
Query!
State/province [31]
0
0
New York
Query!
Country [32]
0
0
United States of America
Query!
State/province [32]
0
0
North Carolina
Query!
Country [33]
0
0
United States of America
Query!
State/province [33]
0
0
North Dakota
Query!
Country [34]
0
0
United States of America
Query!
State/province [34]
0
0
Ohio
Query!
Country [35]
0
0
United States of America
Query!
State/province [35]
0
0
Oklahoma
Query!
Country [36]
0
0
United States of America
Query!
State/province [36]
0
0
Oregon
Query!
Country [37]
0
0
United States of America
Query!
State/province [37]
0
0
Pennsylvania
Query!
Country [38]
0
0
United States of America
Query!
State/province [38]
0
0
Rhode Island
Query!
Country [39]
0
0
United States of America
Query!
State/province [39]
0
0
South Carolina
Query!
Country [40]
0
0
United States of America
Query!
State/province [40]
0
0
South Dakota
Query!
Country [41]
0
0
United States of America
Query!
State/province [41]
0
0
Tennessee
Query!
Country [42]
0
0
United States of America
Query!
State/province [42]
0
0
Texas
Query!
Country [43]
0
0
United States of America
Query!
State/province [43]
0
0
Utah
Query!
Country [44]
0
0
United States of America
Query!
State/province [44]
0
0
Vermont
Query!
Country [45]
0
0
United States of America
Query!
State/province [45]
0
0
Virginia
Query!
Country [46]
0
0
United States of America
Query!
State/province [46]
0
0
Washington
Query!
Country [47]
0
0
United States of America
Query!
State/province [47]
0
0
West Virginia
Query!
Country [48]
0
0
United States of America
Query!
State/province [48]
0
0
Wisconsin
Query!
Country [49]
0
0
Canada
Query!
State/province [49]
0
0
Alberta
Query!
Country [50]
0
0
Canada
Query!
State/province [50]
0
0
British Columbia
Query!
Country [51]
0
0
Canada
Query!
State/province [51]
0
0
Manitoba
Query!
Country [52]
0
0
Canada
Query!
State/province [52]
0
0
Newfoundland and Labrador
Query!
Country [53]
0
0
Canada
Query!
State/province [53]
0
0
Nova Scotia
Query!
Country [54]
0
0
Canada
Query!
State/province [54]
0
0
Ontario
Query!
Country [55]
0
0
Canada
Query!
State/province [55]
0
0
Quebec
Query!
Country [56]
0
0
Canada
Query!
State/province [56]
0
0
Saskatchewan
Query!
Country [57]
0
0
Israel
Query!
State/province [57]
0
0
Petah Tikua
Query!
Country [58]
0
0
New Zealand
Query!
State/province [58]
0
0
Auckland
Query!
Country [59]
0
0
Puerto Rico
Query!
State/province [59]
0
0
San Juan
Query!
Country [60]
0
0
Switzerland
Query!
State/province [60]
0
0
Bern
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Children's Oncology Group
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Government body
Query!
Name [1]
0
0
National Cancer Institute (NCI)
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This phase III trial is studying how well combination chemotherapy with or without radiation
therapy works in treating young patients with newly diagnosed stage III or stage IV Wilms'
tumor. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells,
either by killing the cells or by stopping them from dividing. Radiation therapy uses
high-energy x-rays to kill tumor cells. Giving more than one drug (combination chemotherapy)
with or without radiation therapy may kill more tumor cells.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT00379340
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
David B Dix
Query!
Address
0
0
Children's Oncology Group
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT00379340
Download to PDF